Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07312136Enrolling By Invitation

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

Role: collaborator

NCT07291141Recruiting

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

Role: collaborator

NCT05477277Not ApplicableRecruiting

Adverse Outcomes and Mortality in Liver Transplant

Role: collaborator

NCT05184283Terminated

Utilization of MAsS in Patients Undergoing LT for HCC

Role: collaborator

NCT05502198Recruiting

Relevance of Sarcopenia in Advanced Liver Disease

Role: collaborator

All 5 trials loaded